GSK to cut 900 jobs in North Carolina to reduce expenses
The company is eliminating positions in US commercial and research operations as part of a global restructuring
GlaxoSmithKline Plc (GSK) will cut 900 jobs in North Carolina as part of the UK drug maker’s plan to reduce costs by £1 billion.
Select your Category
Login to enjoy exclusive benefits!
- Unlocked premium articles
- Personalized news
- Market Watchlist
- Insightful Newsletters & more